GF
ABBV icon

Gries Financial’s AbbVie ABBV Stock Holding History

Gries Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.02M Buy
17,355
+131
+0.8% +$26.7K 0.64% 26
2025
Q2 		$3.2M Buy
17,224
+340
+2% +$63.2K 0.58% 30
2025
Q1 		$3.54M Buy
16,884
+844
+5% +$164K 0.69% 25
2024
Q4 		$2.85M Buy
16,040
+62
+0.4% +$11.4K 0.51% 38
2024
Q3 		$3.16M Buy
15,978
+1,190
+8% +$222K 0.59% 31
2024
Q2 		$2.54M Sell
14,788
-865
-6% -$143K 0.52% 43
2024
Q1 		$2.85M Sell
15,653
-576
-4% -$99.3K 0.48% 50
2023
Q4 		$2.52M Sell
16,229
-571
-3% -$83.2K 0.55% 39
2023
Q3 		$2.5M Buy
16,800
+5
+0% +$734 0.67% 30
2023
Q2 		$2.26M Hold
16,795
– – 0.62% 42
2023
Q1 		$2.68M Sell
16,795
-815
-5% -$125K 0.79% 28
2022
Q4 		$2.85M Buy
17,610
+866
+5% +$133K 0.94% 28
2022
Q3 		$2.25M Hold
16,744
– – 0.95% 24
2022
Q2 		$2.56M Sell
16,744
-70
-0.4% -$10.7K 1.22% 17
2022
Q1 		$2.73M Sell
16,814
-5,132
-23% -$745K 1% 22
2021
Q4 		$2.97M Sell
21,946
-5,760
-21% -$680K 1.21% 16
2021
Q3 		$2.99M Sell
27,706
-5,020
-15% -$574K 0.94% 24
2021
Q2 		$3.77M Sell
32,726
-7,055
-18% -$795K 1.21% 16
2021
Q1 		$4.64M Buy
+39,781
New +$4.26M 1.48% 11

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Gries Financial's ABBV Position: Q3 2025 in Review

Gries Financial increased its AbbVie (ABBV) stake by 0.76% in Q3 2025, buying an estimated $26.7K and bringing the position to 17,355 shares worth $4.02M. The position accounts for 0.64% of the portfolio, ranked #26.

Gries Financial first reported a position in ABBV in Q1 2021 and has held it in 19 quarters since. The position peaked at $4.64M in Q1 2021. 3,915 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Gries Financial held 17,355 shares of AbbVie worth $4.02M as of Q3 2025.
  • Gries Financial bought 131 AbbVie shares in Q3 2025, an estimated $26.7K.
  • AbbVie made up 0.64% of Gries Financial's portfolio in Q3 2025, its #26 holding.
  • Gries Financial first reported a position in AbbVie in Q1 2021 and has held it in 19 quarters since.
  • Gries Financial's AbbVie position peaked at $4.64M in Q1 2021.
  • 3,915 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Gries Financial's 13F filing for Q3 2025, filed 22 Oct 2025.